Udkoff, J., & Eichenfield, L. F. (2017). Cost-effectiveness analysis of ixekizumab versus etanercept and their manufacturer recommended dosing regimens in moderate to severe plaque psoriasis. J Drugs Dermatol.
Style de citation ChicagoUdkoff, Jeremy, et Lawrence F. Eichenfield. "Cost-effectiveness Analysis of Ixekizumab Versus Etanercept and Their Manufacturer Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis." J Drugs Dermatol 2017.
Style de citation MLAUdkoff, Jeremy, et Lawrence F. Eichenfield. "Cost-effectiveness Analysis of Ixekizumab Versus Etanercept and Their Manufacturer Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis." J Drugs Dermatol 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.